In vitro activity of a novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), against rapidly growing mycobacteria and Nocardia isolates

被引：8
|
作者：
Valera, L [1 ]
Gradelski, E [1 ]
Huczko, E [1 ]
Washo, T [1 ]
Yigit, H [1 ]
Fung-Tomc, J [1 ]
机构：
[1] Bristol Myers Squibb Co, Dept Microbiol, Wallingford, CT 06492 USA
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 01期
关键词：
D O I：
10.1093/jac/dkf081
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：140A / 142
页数：3
相关论文
共 48 条
  • [31] The structure-activity relationship of BMS284756, a novel des-F(6)-quinolone
    Barrett, JF
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 : 28 - 28
  • [32] In vitro activity of DX-619, a novel des-fluoro(6) quinolone, against a panel of Streptococcus pneumoniae mutants with characterized resistance mechanisms
    Wickman, PA
    Moland, ES
    Black, JA
    Thomson, KS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 796 - 798
  • [33] In Vitro Antibacterial Activity of DX-619, A Novel Des-Fluoro(6)-Quinolone, Against Multidrug-resistant Gram-positive Bacteria
    Fujikawa, Katsuko
    Ishida, Hiroko
    Chiba, Megumi
    Tanaka, Mayumi
    Sato, Kenichi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S79 - S79
  • [34] In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone (Vol 49, pg 3040, 2005)
    Fujikawa, K
    Chiba, M
    Tanaka, M
    Sato, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) : 3988 - 3988
  • [35] Safety, tolerability, and pharmacokinetics of BMS-284756, a novel des-F(6)-quinolone, following 14-day oral doses in healthy adult subjects
    Grasela, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 : 39 - 40
  • [36] In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest
    Brown-Elliott, Barbara A.
    Killingley, Jessica
    Vasireddy, Sruthi
    Bridge, Linda
    Wallace, Richard J., Jr.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (06) : 1586 - 1592
  • [37] Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids - Discovery of the novel Des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756)
    Hayashi, K
    Takahata, M
    Kawamura, Y
    Todo, Y
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2002, 52 (12): : 903 - 913
  • [38] In vitro activity of omadacycline against geographically diverse rapidly growing nontuberculous mycobacteria (NTM) clinical isolates
    Terschlusen, Eva
    Aono, Akio
    Anastasiou, Diane M.
    Serio, Alisa W.
    Mitarai, Satoshi
    van Ingen, Jakko
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (03)
  • [39] In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model
    Fukuda, Y
    Yanagihara, K
    Ohno, H
    Higashiyama, Y
    Miyazaki, Y
    Tsukamoto, K
    Hirakata, Y
    Tomono, K
    Mizuta, Y
    Tashiro, T
    Kohno, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 121 - 125
  • [40] In vitro antibacterial activity of DX-619, a novel Des-F (6)-quinolone against clinical isolates in China
    Xiao, Yonghong
    Li, Yun
    Liu, Jian
    Zhong, Wei
    Yang, Weiwei
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (06) : 632 - 642
12345